Imagene AI provides AI-based molecular diagnosis for cancer, leveraging the patient's histological data for personalized therapy. Our mission is to assist cancer patients in receiving the optimal treatment medicine can offer by leveraging AI to detect, in real-time, a broad range of cancerous biomarkers and genomic insights from the biopsy image alone. By doing so, Imagene overcomes economical, logistical, and technological barriers to reach the full potential of precision medicine for cancer patients. Through collaborations with top-tier medical centers and pharmaceutical companies, Imagene is revolutionizing molecular screening for both clinical practice and research. Our success derives from our cutting-edge technology and talented multidisciplinary team of data scientists, biologists, software engineers, and medical experts. If you want to join us in our mission to create a true impact on cancer patients, we would like to hear from you.
Total Funding: N/A
Funding Stage: N/A
Business Stage: Scaling Up
Market: B2B
Company Size: 1 to 25
Founded: 2020
For AI/ML Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI/ML Startup founders or founders at Imagene AI
Dean Bitan
Chief Executive Officer
Jonathan Zalach
Co-Founder & Chief Data Scientist
Shahar Porat
Co-Founder & Chief Technology Officer
Efrat Rahat
VP of HR
Will Brown
Vice President , Head of Strategic Partnerships
Senior Data Scientist
Tel Aviv
Senior Full Stack Engineer
Tel Aviv
DevOps Engineer
Tel Aviv
Head of Science
Tel Aviv